InvestorsHub Logo
Followers 1
Posts 54
Boards Moderated 0
Alias Born 09/26/2012

Re: None

Friday, 03/29/2013 3:11:31 PM

Friday, March 29, 2013 3:11:31 PM

Post# of 124

Came across this article on ANAC:

http://www.marketwatch.com/story/3-stock-picks-from-the-next-david-einhorn-2013-03-29?pagenumber=2

Michael Castor also summarized his investment thesis in another small-cap stock in his February investor letter: Anacor Pharmaceuticals ANAC -0.62% . He talked about the stock because it lost 12.5% of its value in February, but Castor said he is long-term bullish about the stock. Here is what he said:

"We had only one notable loser in the portfolio in February, Anacor Pharmaceuticals. This is an interesting little company that we like for the long term. We foresee four ways to win with our investment in Anacor.

“First, Anacor has a drug to treat toenail fungus. This product has successfully completed two late-stage clinical trials. It is safe and effective.